4 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Inflammation, Brain: new trials by email Literature Review of Inflammation, Brain trials Research Report on Inflammation, Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment Lenalidomide 10 mg - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Not yet recruiting | St. Joseph's Hospital and Medical Center, Phoenix | 45 | 2025-06-01 | 2025-05-18 |
| Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL InflammatorY Insults Infection during pregnancy - Biomarkers, Neurodevelopmental Disorders | Recruiting | Istituto Clinico Humanitas | 300 | 2021-09-01 | 2025-02-28 | |
| MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients Lenalidomide 10 mg, Placebo - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Completed | St. Joseph's Hospital and Medical Center, Phoenix | 15 | 2020-07-22 | 2026-06-10 |
| Dysautonomia and Systemic Interactions in Traumatic Brain Injury Traumatic Brain Injury, Dysautonomia | Unknown | Karolinska University Hospital | 24 | 2019-08-01 | 2024-03-08 | |
| Efficacy Evaluation of the Mushroom Beverage on Emotion Regulation beverage containing mushroom-extracts - Inflammation, Brain, Emotional Problem | Not applicable | Completed | National Science and Technology Council, Taiwan | 80 | 2019-07-01 | 2022-10-10 |
| PRIME: Cognitive Outcome Following Major Burns Cognitive Dysfunction, Burns | Completed | Chelsea and Westminster NHS Foundation Trust | 30 | 2014-10-01 | 2017-08-08 | |
| Control of Leukocyte Function No intervention (drugs) will be given. Purpose: collecting blood for in vitro studies - Inflammation, Brain | Completed | Beth Israel Deaconess Medical Center | 100 | 2007-01-01 | 2018-04-27 |
Encephalitis (7) · Cognitive Dysfunction (3) · Alzheimer Disease (2) · Plaque, Amyloid (2) · Anxiety Disorders (1) · Autonomic Nervous System Diseases (1) · Brain Injuries, Traumatic (1) · Burns (1) · Depression (1) · Heredodegenerative Disorders, Nervous System (1) · Infections (1) · Memory Disorders (1) · Nerve Degeneration (1) · Neurodevelopmental Disorders (1) · Neuroinflammatory Diseases (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Nervous System Diseases (7) · Neuroinflammatory Diseases (6) · Mental Disorders (4) · Cognition Disorders (3) · Neurocognitive Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Dementia (2) · Neurodegenerative Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Anatomical (2) · Tauopathies (2) · Wounds and Injuries (2) · Behavior (1)
Lenalidomide (2) · Pharmaceutical Preparations (1)
St. Joseph's Hospital and Medical Center, Phoenix (2) · Beth Israel Deaconess Medical Center (1) · Chelsea and Westminster NHS Foundation Trust (1) · Istituto Clinico Humanitas (1) · Karolinska University Hospital (1) · National Science and Technology Council, Taiwan (1)
United States (2) · Italy (1) · Sweden (1) · Taiwan (1) · United Kingdom (1)
Boris Decourt, PhD (1) · David W Nelson, M.D., Ph.D. (1) · Kuan-Pin Su, MD, PhD (1) · Marcela P Vizcaychipi, MD PhD (1) · Marwan N Sabbagh, M.D. (1)
K01AG047279 (1), R01AG059008 (1)